Learn about optimal timing, dosing frequency, and how to maximize results from your
Treatment with once-weekly cagrilintide (0.16, 0.30, 0.60, 1.2, 2.4, and 4.5 mg) in combination with semaglutide 2.4 mg for 20 weeks was not associated with an increase in adverse events compared with placebo in combination with semaglutide 2.4 mg, with no unexpected safety or tolerability findings
Its uncommon, but some patients report a temporary increase in energy that can feel overstimulating at firstespecially if their levels were very low
Depending on the research objective, other compounds may be more appropriate
and managing diarrhea (69)
Allergen warning: may contain traces of allergens